Cytokine storm and development of autoimmune diseases as a sequel of Covid-19
Autor(a) principal: | |
---|---|
Data de Publicação: | 2021 |
Outros Autores: | , , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Research, Society and Development |
Texto Completo: | https://rsdjournal.org/index.php/rsd/article/view/19385 |
Resumo: | Introduction: Researchers at Rockefeller University, New York, found in some seriously ill patients with Covid-19 a type of autoantibody that attacks other cells of the immune system. For scientists, this would be an indication that these patients had preexisting autoantibodies to the disease and that this would be the reason why they developed the severe form of Covid-19. Objective: Answer what is the evidence on the infection by Sars-CoV-2 and triggering of autoimmunity. Methodology: This is a descriptive research of the integrative literature review type, which sought to answer what is the evidence on Sars-CoV-2 infection and triggering of autoimmunity. The search was carried out through online access in the National Library of Medicine (PubMed MEDLINE), Scientific Electronic Library Online (Scielo), Cochrane Database of Systematic Reviews (CDSR), Google Scholar, Virtual Health Library (BVS) and EBSCO databases Information Services, July 2021. Results: It is believed that Covid-19 has clinical characteristics similar to autoimmune diseases, as both share major immune responses of pathogenesis. Case reports of patients who developed Guillain-Barré syndrome, autoimmune hemolytic anemia and systemic lupus erythematosus were presented. Conclusion: Sars-CoV-2 can alter self-tolerance and generate autoimmune responses through cross-reactivity with host cells. However, it will be up to the scientific community to investigate this possibility further to validate or disprove this hypothesis, given the ease of detecting autoantibodies, thus corroborating the finding that they, triggered or not by Covid-19, are really a threat of alteration in the immune system. |
id |
UNIFEI_65ec5f82f12b3c3b438c4aeb5e3ff86c |
---|---|
oai_identifier_str |
oai:ojs.pkp.sfu.ca:article/19385 |
network_acronym_str |
UNIFEI |
network_name_str |
Research, Society and Development |
repository_id_str |
|
spelling |
Cytokine storm and development of autoimmune diseases as a sequel of Covid-19Tormenta de citocinas y desarrollo de enfermidades autoimunes como secuela de Covid-19 Tempestade de citocinas e desenvolvimento de doenças autoimunes como sequela da Covid-19Covid-19AutoinmunidadCitocinasSistema inmunológico.Covid-19AutoimmunityCytokinesImmune system.Covid-19AutoimunidadeCitocinasSistema imunológico.Introduction: Researchers at Rockefeller University, New York, found in some seriously ill patients with Covid-19 a type of autoantibody that attacks other cells of the immune system. For scientists, this would be an indication that these patients had preexisting autoantibodies to the disease and that this would be the reason why they developed the severe form of Covid-19. Objective: Answer what is the evidence on the infection by Sars-CoV-2 and triggering of autoimmunity. Methodology: This is a descriptive research of the integrative literature review type, which sought to answer what is the evidence on Sars-CoV-2 infection and triggering of autoimmunity. The search was carried out through online access in the National Library of Medicine (PubMed MEDLINE), Scientific Electronic Library Online (Scielo), Cochrane Database of Systematic Reviews (CDSR), Google Scholar, Virtual Health Library (BVS) and EBSCO databases Information Services, July 2021. Results: It is believed that Covid-19 has clinical characteristics similar to autoimmune diseases, as both share major immune responses of pathogenesis. Case reports of patients who developed Guillain-Barré syndrome, autoimmune hemolytic anemia and systemic lupus erythematosus were presented. Conclusion: Sars-CoV-2 can alter self-tolerance and generate autoimmune responses through cross-reactivity with host cells. However, it will be up to the scientific community to investigate this possibility further to validate or disprove this hypothesis, given the ease of detecting autoantibodies, thus corroborating the finding that they, triggered or not by Covid-19, are really a threat of alteration in the immune system.Introducción: Investigadores de la Universidad Rockefeller, Nueva York, han encontrado en algunos pacientes gravemente enfermos con Covid-19 un tipo de autoanticuerpo que ataca a otras células del sistema inmunológico. Para los científicos, esto sería una indicación de que estos pacientes tenían autoanticuerpos preexistentes contra la enfermedad y que esta sería la razón por la que desarrollaron la forma severa de Covid-19. Objetivo: Responder cuál es la evidencia sobre la infección por Sars-CoV-2 y desencadenamiento de autoinmunidad. Metodología: Se trata de una investigación descriptiva del tipo revisión integradora de la literatura, que buscó dar respuesta a cuál es la evidencia sobre la infección por Sars-CoV-2 y el desencadenamiento de autoinmunidad. La búsqueda se realizó a través del acceso online en la Biblioteca Nacional de Medicina (PubMed MEDLINE), Scientific Electronic Library Online (Scielo), Cochrane Database of Systematic Reviews (CDSR), Google Scholar, Virtual Health Library (BVS) y bases de datos EBSCO Information Services, Julio de 2021. Resultados: Se cree que Covid-19 tiene características clínicas similares a las enfermedades autoinmunes, ya que ambas comparten las principales respuestas inmunitarias de patogénesis. Se presentaron informes de casos de pacientes que desarrollaron síndrome de Guillain-Barré, anemia hemolítica autoinmune y lupus eritematoso sistémico. Conclusión: Sars-CoV-2 puede alterar la auto-tolerancia y generar respuestas autoinmunes a través de reactividad cruzada con células huésped. Sin embargo, corresponderá a la comunidad científica investigar más a fondo esta posibilidad para validar o refutar esta hipótesis, dada la facilidad para detectar autoanticuerpos, corroborando así el hallazgo de que, desencadenados o no por Covid-19, son realmente una amenaza de alteración. en el sistema inmunológico.Introdução: Pesquisadores da Universidade de Rockefeller, em Nova York, encontraram em alguns doentes graves por Covid-19 um tipo de autoanticorpo que ataca outras células do sistema imunológico. Para os cientistas, isso seria um indício de que esses pacientes tinham autoanticorpos preexistentes à doença e que esse seria o motivo pelo qual desenvolveram a forma grave da Covid-19. Objetivo: Responder quais as evidências sobre a infecção por Sars-CoV-2 e desencadeamento de autoimunidade. Metodologia: Trata-se de uma pesquisa descritiva do tipo revisão integrativa da literatura, que buscou responder quais as evidências sobre a infecção por Sars-CoV-2 e desencadeamento de autoimunidade. A pesquisa foi realizada através do acesso online nas bases de dados National Library of Medicine (PubMed MEDLINE), Scientific Electronic Library Online (Scielo), Cochrane Database of Systematic Reviews (CDSR), Google Scholar, Biblioteca Virtual em Saúde (BVS) e EBSCO Information Services, no mês de julho de 2021. Resultados: Acredita-se que o Covid-19 possua características clínicas semelhantes às doenças autoimunes, pois ambas compartilham grandes reações imunes da patogênese. Relatos de caso de pacientes que desenvolveram síndrome de Guillain-Barré, anemia hemolítica autoimune e lúpus eritematoso sistêmico foram expostos. Conclusão: O Sars-CoV-2 pode alterar a autotolerância e gerar respostas autoimunes através da reatividade cruzada com células hospedeiras. No entanto, ficará a cargo da comunidade científica investigar essa possibilidade mais a fundo para validar ou reprovar essa hipótese, haja vista a facilidade em detectar autoanticorpos, corroborando, dessa forma, a constatação de que eles, desencadeados ou não pela Covid-19, são realmente uma ameaça de alteração no sistema imunológico.Research, Society and Development2021-08-22info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/1938510.33448/rsd-v10i11.19385Research, Society and Development; Vol. 10 No. 11; e38101119385Research, Society and Development; Vol. 10 Núm. 11; e38101119385Research, Society and Development; v. 10 n. 11; e381011193852525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIporhttps://rsdjournal.org/index.php/rsd/article/view/19385/17252Copyright (c) 2021 Bárbara Queiroz de Figueiredo; Ana Paula Ferreira Araújo; Carlos Daniel Silva; Diego Arthur Castro Cabral; Gardênia Silva Amorim; Gustavo Alves Medeiros; Isadora Queiroz Presot; Júlia de Mendonça Queiroz; Luana Damaceno Miranda; Maria Paula Pereira Lessa; Vinícius Slonski Delbonihttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessFigueiredo, Bárbara Queiroz deAraújo, Ana Paula FerreiraSilva, Carlos DanielCabral, Diego Arthur CastroAmorim, Gardênia SilvaMedeiros, Gustavo AlvesPresot, Isadora QueirozQueiroz, Júlia de MendonçaMiranda, Luana DamacenoLessa, Maria Paula PereiraDelboni, Vinícius Slonski2021-10-23T19:01:11Zoai:ojs.pkp.sfu.ca:article/19385Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:39:17.427039Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false |
dc.title.none.fl_str_mv |
Cytokine storm and development of autoimmune diseases as a sequel of Covid-19 Tormenta de citocinas y desarrollo de enfermidades autoimunes como secuela de Covid-19 Tempestade de citocinas e desenvolvimento de doenças autoimunes como sequela da Covid-19 |
title |
Cytokine storm and development of autoimmune diseases as a sequel of Covid-19 |
spellingShingle |
Cytokine storm and development of autoimmune diseases as a sequel of Covid-19 Figueiredo, Bárbara Queiroz de Covid-19 Autoinmunidad Citocinas Sistema inmunológico. Covid-19 Autoimmunity Cytokines Immune system. Covid-19 Autoimunidade Citocinas Sistema imunológico. |
title_short |
Cytokine storm and development of autoimmune diseases as a sequel of Covid-19 |
title_full |
Cytokine storm and development of autoimmune diseases as a sequel of Covid-19 |
title_fullStr |
Cytokine storm and development of autoimmune diseases as a sequel of Covid-19 |
title_full_unstemmed |
Cytokine storm and development of autoimmune diseases as a sequel of Covid-19 |
title_sort |
Cytokine storm and development of autoimmune diseases as a sequel of Covid-19 |
author |
Figueiredo, Bárbara Queiroz de |
author_facet |
Figueiredo, Bárbara Queiroz de Araújo, Ana Paula Ferreira Silva, Carlos Daniel Cabral, Diego Arthur Castro Amorim, Gardênia Silva Medeiros, Gustavo Alves Presot, Isadora Queiroz Queiroz, Júlia de Mendonça Miranda, Luana Damaceno Lessa, Maria Paula Pereira Delboni, Vinícius Slonski |
author_role |
author |
author2 |
Araújo, Ana Paula Ferreira Silva, Carlos Daniel Cabral, Diego Arthur Castro Amorim, Gardênia Silva Medeiros, Gustavo Alves Presot, Isadora Queiroz Queiroz, Júlia de Mendonça Miranda, Luana Damaceno Lessa, Maria Paula Pereira Delboni, Vinícius Slonski |
author2_role |
author author author author author author author author author author |
dc.contributor.author.fl_str_mv |
Figueiredo, Bárbara Queiroz de Araújo, Ana Paula Ferreira Silva, Carlos Daniel Cabral, Diego Arthur Castro Amorim, Gardênia Silva Medeiros, Gustavo Alves Presot, Isadora Queiroz Queiroz, Júlia de Mendonça Miranda, Luana Damaceno Lessa, Maria Paula Pereira Delboni, Vinícius Slonski |
dc.subject.por.fl_str_mv |
Covid-19 Autoinmunidad Citocinas Sistema inmunológico. Covid-19 Autoimmunity Cytokines Immune system. Covid-19 Autoimunidade Citocinas Sistema imunológico. |
topic |
Covid-19 Autoinmunidad Citocinas Sistema inmunológico. Covid-19 Autoimmunity Cytokines Immune system. Covid-19 Autoimunidade Citocinas Sistema imunológico. |
description |
Introduction: Researchers at Rockefeller University, New York, found in some seriously ill patients with Covid-19 a type of autoantibody that attacks other cells of the immune system. For scientists, this would be an indication that these patients had preexisting autoantibodies to the disease and that this would be the reason why they developed the severe form of Covid-19. Objective: Answer what is the evidence on the infection by Sars-CoV-2 and triggering of autoimmunity. Methodology: This is a descriptive research of the integrative literature review type, which sought to answer what is the evidence on Sars-CoV-2 infection and triggering of autoimmunity. The search was carried out through online access in the National Library of Medicine (PubMed MEDLINE), Scientific Electronic Library Online (Scielo), Cochrane Database of Systematic Reviews (CDSR), Google Scholar, Virtual Health Library (BVS) and EBSCO databases Information Services, July 2021. Results: It is believed that Covid-19 has clinical characteristics similar to autoimmune diseases, as both share major immune responses of pathogenesis. Case reports of patients who developed Guillain-Barré syndrome, autoimmune hemolytic anemia and systemic lupus erythematosus were presented. Conclusion: Sars-CoV-2 can alter self-tolerance and generate autoimmune responses through cross-reactivity with host cells. However, it will be up to the scientific community to investigate this possibility further to validate or disprove this hypothesis, given the ease of detecting autoantibodies, thus corroborating the finding that they, triggered or not by Covid-19, are really a threat of alteration in the immune system. |
publishDate |
2021 |
dc.date.none.fl_str_mv |
2021-08-22 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/19385 10.33448/rsd-v10i11.19385 |
url |
https://rsdjournal.org/index.php/rsd/article/view/19385 |
identifier_str_mv |
10.33448/rsd-v10i11.19385 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/19385/17252 |
dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Research, Society and Development |
publisher.none.fl_str_mv |
Research, Society and Development |
dc.source.none.fl_str_mv |
Research, Society and Development; Vol. 10 No. 11; e38101119385 Research, Society and Development; Vol. 10 Núm. 11; e38101119385 Research, Society and Development; v. 10 n. 11; e38101119385 2525-3409 reponame:Research, Society and Development instname:Universidade Federal de Itajubá (UNIFEI) instacron:UNIFEI |
instname_str |
Universidade Federal de Itajubá (UNIFEI) |
instacron_str |
UNIFEI |
institution |
UNIFEI |
reponame_str |
Research, Society and Development |
collection |
Research, Society and Development |
repository.name.fl_str_mv |
Research, Society and Development - Universidade Federal de Itajubá (UNIFEI) |
repository.mail.fl_str_mv |
rsd.articles@gmail.com |
_version_ |
1797052687578038272 |